SureTrader
Interactive Brokers Advertisement
Home > Boards > US OTC > Computers - Software >

Appyea, Inc. (APYP)

APYP RSS Feed
Add APYP Price Alert      Hide Sticky   Hide Intro
Moderator: Raphael De La Ghetto, YeralHax, GOLDBUFFALO
Search This Board: 
Last Post: 12/17/2017 2:39:28 PM - Followers: 170 - Board type: Free - Posts Today: 1


APPYEA Game and Mobile App Development
Premium Apps for Business and Gaming
www.appyea.com
 
CURRENT SHARE STRUCTURE
  Market Value1 $532,293 a/o Dec 08, 2017
Authorized Shares 1,500,000,000 a/o Dec 01, 2017
Outstanding Shares 887,154,334 a/o Dec 01, 2017

 


Current news regarding Appyea subsidiary The Diagnostic Centers, Inc.

AppYea Signs Sales and Marketing Agreement with Syncier BioTech

FORT WORTH, TX -- (Marketwired) -- 11/28/17 -- AppYea, Inc, (OTC PINK: APYP) announced today that its subsidiary, The Diagnostic Centers, has entered into a sales and Marketing Agreement with Syncier BioTech Inc. to strengthen its Pharmacogenetic ("PGx") testing capabilities and service offerings.

Syncier offers a suite of comprehensive genetic tests including (i) cancer pre-disposition, which provides patients a strong understanding of whether they have an increased risk of developing certain cancers, (ii) patient's tolerance and effects of prescription drugs, which shows how a patient's genes respond to different prescription drugs allowing the physician to tailor a patient's treatment with safe effective drugs, (iii) blood wellness, which helps determine a patient's overall wellness and understand what's going on inside the body at a metabolic level and (iv) respiratory pathogen tests which help a physician understand which pathogen is effecting the patient's respiratory.

PGx testing provides insight into a patient's metabolic pathways. Knowing which pathways are functioning normally or abnormally allows a physician to prescribe medications as intended by the drug manufacturer, select the most appropriate dose, and even the best drug for the patient.

"We continue to look for advanced products and service that we can market to our doctor groups and clinics. With the ability to offer these advanced tests we can attract a broader base of healthcare providers," said Douglas McKinnon, AppYea's CEO. "Additionally, PGx testing is a much higher revenue generator than basic blood and toxicology test, resulting in increased margins."

 

AppYea's Subsidiary The Diagnostic Centers Signs First New Client

FORT WORTH, TX -- (Marketwired) -- 11/02/17 -- AppYea Inc. (OTC PINK: APYP) announced today that its subsidiary The Diagnostic Centers has signed its first new client, Pacific Pain & Regenerative Medicine, with locations in Los Angeles and Irvine, California and has started shipping PGx samples for testing.

Under this new agreement, Pacific Pain & Regenerative Medicine guarantees a minimum of 20 PGx tests per month which will generate between $20,000 and $40,000 per month of revenue to the Company, depending on the test. Pharmacogenetic (PGx) testing is used for determining how an individual will respond to a particular medicine. Clinicians use PGx testing to provide personalized medicine rather than using the population-based or one size fits all approach. PGx testing may also improve medication adherence.

PGx testing provides insight into a patient's metabolic pathways. Knowing which pathways are functioning normally or abnormally allows a physician to prescribe medications as intended by the drug manufacturer, select the most appropriate dose, and even the best drug for the patient.

"This is the first step in signing up doctor groups and clinics. As we demonstrate successful and timely testing, it will allow us to add toxicology testing for their patents as well. Based on the number of samples per month we will see a significant change in the way we do business as a company," Douglas McKinnon, AppYea's CEO, stated. "If we manage 1000 tests per month for doctor groups we are looking at a completely different company."

 

AppYea Announces Sales and Marketing Team for Its Diagnostic Centers Inc.

FORT WORTH, TX -- (Marketwired) -- 09/20/17 -- APPYEA Inc. (OTC PINK: APYP) announced on August 14th, 2017 that it formed a new subsidiary, The Diagnostic Centers Inc., to focus on marketing certain products and services to healthcare providers.

The Diagnostic Centers Inc. has partnered with two new sales professionals to help build its team. Frank Molak will head up the new sales and marketing division and provide support to its employees and guidance. Frank helped launch the pharmacy discount card company WaterTree Health that is now a nationally recognized pharmacy discount program.

We also added Josh Booty who not only played in the MLB for several years including playing third base for the 1997 World Series Champion team the Florida Marlins, but also played in the NFL for the Seahawks, Browns and Raiders. "His commitment to excellence is what attracted us to hiring this individual," stated Douglas McKinnon, CEO of AppYea. After Josh's playing days, he has excelled in business development and consulting for many companies including Athletes 1st, a football sports agency. Josh has also worked with FoxSports, FOXSports.com, ESPN, ESPN Radio, SiriusXM, GridironNow.com, CBS Sports and MLB Network as a radio, internet and TV personality.

Formerly the spokesperson for TrueMRI in Beverly Hills, California, his focus now is to use the contacts that he has developed in both sports and business to drive sales and marketing to this national medical laboratory services marketing company.

Doug McKinnon stated, "I am pleased to welcome these talented individuals to our sales and marketing team as the company takes on exciting new developments with its subsidiary."



Current news regarding Appyea and the development of New APPS

AppYea Launches Three New Apps on Google Play

FORT WORTH, TX -- (Marketwired) -- 10/17/17 -- AppYea Inc (OTC PINK: APYP) announced today that it has released two new gaming apps and one pharmaceutical savings app on Google Play for the Android systems and will soon release the games on Apple's iTunes for the iPhone and iOS Platform.

The two new gaming apps are kid friendly and will be available in the in-app purchasing system for download. The first game is titled Duck Quest and is a challenging game where the objective is to fly a funny duck avoiding treacherous obstacles. The longer you stay in the air the more points you accumulate. A fun and engaging experience that will have you hooked in no time.

The second kid friendly game is Ball Bearing Racer, a simple but fun racing simulation where you can pick your character and race through large cities, avoiding obstacles in your path and earning rewards along the way.

Lastly with the new app Cheap RX, you can immediately save money on prescriptions for the entire family; you can save an estimated 10% to 85% on most generic and brand name prescriptions. There is no cost to use this app and you and your family can use it as often as you like at any of the 60,000 participating pharmacies nationwide! Revenues will come from advertising and or charging for add-ons or the app itself.

"Although the company previously announced that it has entered the healthcare services market, we will continue adding new apps and redeveloping the mobile applications that we have in our pipeline in an effort to drive revenues to the company," stated AppYea's CEO Douglas McKinnon.

According to Statista Inc. who tracks the global mobile application market, in 2015, global mobile app revenues amounted to 69.7 billion U.S. dollars. In 2020, mobile apps are projected to generate 188.9 billion U.S. dollars in revenues via app stores and in-app advertising.



CEO Mckinnon just trashed commons here... what a POS.... been waiting over a year for this sob to do something other than pay his salary.... 

http://archive.fast-edgar.com/20170606/AB22A22CZ222H2Z2222I2C3GGTL85C22I292 

The Board of Directors and the Majority Stockholders have approved, an increase in our authorized common shares from 750,000,000 to 1,500,000,000. The Board of Directors has determined that this increase in the Company’s authorized shares is advisable and in the best interests of us and our stockholders. 
Best intrest of who???? Not commons that's for sure
 

                                

.

 
 
SureTrader
Interactive Brokers Advertisement
APYP
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
APYP News: Quarterly Report (10-q) 11/14/2017 11:46:43 AM
APYP News: Current Report Filing (8-k) 10/26/2017 12:04:44 PM
APYP News: Annual Report (10-k) 10/13/2017 04:55:01 PM
APYP News: Notification That Annual Report Will Be Submitted Late (nt 10-k) 09/29/2017 11:27:27 AM
PostSubject
#18960  Sticky Note $APYP 3 Months Chart http://www.stockscores.c $Pistol Pete$ 12/10/17 07:50:46 PM
#18940  Sticky Note AppYea Signs Sales and Marketing Agreement with Syncier BioTech YeralHax 12/08/17 02:48:14 PM
#18510  Sticky Note New CEO Mckinnon just trashed commons here... what HDOGTX 06/06/17 05:46:27 PM
#19002   What’s happening this coming week . I’m checking all lordgod 12/17/17 02:39:28 PM
#19000   Lol k832012 12/16/17 04:47:38 PM
#18999   That was some good trading action lordgod 12/15/17 04:41:08 PM
#18998   7’s will drop. This will clear trips and YeralHax 12/15/17 01:07:11 PM
#18997   7 UP NOW COMING YOUR WAY!!! Danthecarman 12/15/17 01:06:36 PM
#18996   Hit them 7’s! Make them fall! Raphael De La Ghetto 12/15/17 01:05:32 PM
#18995   I guess I better get to etrade and lordgod 12/15/17 12:55:39 PM
#18994   VOLUME SHOULD REALLY PICK UP NOW!!! Danthecarman 12/15/17 12:44:14 PM
#18993   THAT IS THE PLAN!!! Danthecarman 12/15/17 12:43:26 PM
#18992   Yes looks like thats a plan Multi-Bagger 12/15/17 12:34:35 PM
#18991   APYP .0006 falling, here we gooooooo $treet Trader 12/15/17 12:32:52 PM
#18990   Nice L2 set up here Rainer 12/15/17 12:32:48 PM
#18989   I said a while back that it would lordgod 12/15/17 12:31:05 PM
#18988   SO NOW YOU KNOW TOO... Danthecarman 12/15/17 12:29:32 PM
#18987   Blockchain technology with diagnostic centers would be a YeralHax 12/15/17 12:28:00 PM
#18986   COPPER Danthecarman 12/15/17 12:27:58 PM
#18985   AND STILL HAVE TIME SO BUY BUY BUY Danthecarman 12/15/17 12:27:28 PM
#18984   In the past news it’s about doctors and lordgod 12/15/17 12:26:32 PM
#18983   BIGGER THAN BIG IF YOU ONLY KNEW AND Danthecarman 12/15/17 12:24:26 PM
#18982   $APYP has so much going for it. YeralHax 12/15/17 12:19:43 PM
#18981   ITS NOW !!! RUN FORREST RUN !!! Danthecarman 12/15/17 12:16:05 PM
#18980   Lol...yep. Wasn't me, but I'm sitting at 0005 ol_crow 12/15/17 11:58:29 AM
#18979   APYP .0006 starting, seller reducing his ask size $treet Trader 12/15/17 11:55:32 AM
#18978   Ask pull with 350k hit lol. Someone trying Multi-Bagger 12/15/17 11:55:31 AM
#18977   Something is coming !! lordgod 12/15/17 11:54:38 AM
#18976   Not really a lot of money there either. YeralHax 12/15/17 11:33:34 AM
#18975   ask just doubled, so someone wants out. ol_crow 12/15/17 11:29:40 AM
#18974   So do we swoop on the moron at YeralHax 12/15/17 11:25:54 AM
#18973   Little life here. Let's see if those ol_crow 12/15/17 11:14:38 AM
#18972   True. But on the other end of that YeralHax 12/15/17 10:14:26 AM
#18971   Dang somebody got that 2mill lucky k832012 12/15/17 10:12:35 AM
#18970   Suck the player out low and then shwabaaam! YeralHax 12/15/17 09:50:52 AM
#18969   Doug might be looking for that bitcoin transactional Raphael De La Ghetto 12/12/17 10:19:20 PM
#18968   IDK, but the ask side of L2 is ol_crow 12/12/17 03:42:21 PM
#18967   Is there any new news ? lordgod 12/12/17 12:09:06 PM
#18966   Keep the news coming, Doug! YeralHax 12/12/17 12:02:05 PM
#18965   Nice update on the Ibox! Looks good. Most Raphael De La Ghetto 12/11/17 08:01:26 PM
#18964   Still dumping no shares here. mrwilson31 12/11/17 02:52:07 PM
#18963   Why buy when it always goes down lordgod 12/11/17 02:29:25 PM
#18962   44 million on the bid. Looking good this YeralHax 12/11/17 09:34:35 AM
#18961   Any news today !! lordgod 12/11/17 09:07:54 AM
#18960   $APYP 3 Months Chart http://www.stockscores.c $Pistol Pete$ 12/10/17 07:50:46 PM
#18959   They need a app with pay your doctor lordgod 12/10/17 02:16:03 PM
#18958   We already know what the revenue potential looks YeralHax 12/10/17 11:53:08 AM
#18957   These 2 sales men working for APYP is lordgod 12/10/17 11:43:59 AM
#18956   AppYea Announces Sales and Marketing Team for Its YeralHax 12/10/17 10:59:57 AM
#18953   You dont want me commenting on this pile GOLDBUFFALO 12/09/17 05:55:44 PM
#18952   You can see someone soaking up 100s of lordgod 12/09/17 05:30:30 PM
#18951   How long have the T trades been going esi23 12/09/17 04:34:44 PM
#18949   Someone or some entity is soaking up all Raphael De La Ghetto 12/08/17 04:01:28 PM
PostSubject